Brief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
11/06/2026 21:39
BRIEF-Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development June 11 (Reuters) - ZYUS Life Sciences Corp ZYUS.V:
ZYUS LIFE SCIENCES ANNOUNCES STRATEGIC REALIGNMENT TO PRIORITIZE DRUG DEVELOPMENT
ZYUS LIFE SCIENCES - ANNOUNCES STRATEGIC REALIGNMENT TO FOCUS ON DRUG DEVELOPMENT
ZYUS LIFE SCIENCES - TO DISCONTINUE INTERNATIONAL BUSINESS DEVELOPMENT AND WIND DOWN INTERNATIONAL LEGAL ENTITIES
ZYUS LIFE SCIENCES CORP: REALIGNMENT INCLUDES STREAMLINING OF OPERATIONS AND LEADERSHIP STRUCTURE
Source text: ID:nCNWTVRr7a
Further company coverage: ZYUS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan